课题基金 / 基金详情

Measuring Multimorbidity with Individualized Disease-specific QOL Impact Scales

Measuring Multimorbidity with Individualized Disease-specific QOL Impact Scales
使用个体化疾病特定 QOL 影响量表测量多重发病率
批准号:
8727875
负责人:
JOHN E WARE
金额:
$18.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2015-10-31

项目摘要

项目成果

JOHN E WARE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):有充分的证据表明,多重疾病或多重慢性疾病(MCC)会损害患者的功能和健康相关的生活质量(QOL)。然而,我们研究多重发病的影响和解释的能力受到其概念化和测量方法问题的阻碍。这些问题包括缺乏统一的定义,多种多样的多病指数激增,普遍依赖使用人口权重的指数,而这些指数没有被开发出来解释患者生活质量的变化,以及缺乏将疾病负担的个人评估考虑在内的指数。本项目的目的是改进MCC影响的评估,以分析和解释通用患者报告结果(PRO)衡量生活质量的方法。根据NIA赞助的疾病影响计算机化适应性评估(DICAT)拨款(R44 AG025589, Ware, PI),我们将对2011年和2012年收集的10,624名成年人的横断面和纵向数据进行二次分析,这些成年人来自两个独立的样本(一个样本代表美国普通人群,另一个样本来自预先确定患有关节炎、心血管疾病、慢性肾脏疾病、糖尿病或呼吸系统疾病的成年人)。对于36种情况,DICAT开发了标准化的疾病特异性量表来衡量每种情况对生活质量的影响。这些特定疾病的生活质量影响评分已经在逐个疾病的基础上进行了评估,但尚未进行集体评估,以确定它们如何很好地衡量多病及其影响。我们建议扩展这项工作,以更好地了解患者在MCC背景下将有效的生活质量归因于个体条件的能力。我们还将确定在存在MCC的情况下,汇总特定病情患者生活质量影响评分的替代方法差异的重要性,特别是为了分析和解释通用PROs。本项目有以下具体目的:(1)探索MCC患者在报告疾病对生活质量的影响时,能在多大程度上对特定条件作出有效归因。(2)系统评价用于预测非专利PRO结果的不同MCC聚合方法。(3)用独立数据交叉验证方法和结果。可能需要进行更多的研究,以充分实施在这项研究中证明有用的方法进展。然而,概念化和测量本项目评估的MCC影响的方法最终可能使使用标准化的基于PRO的MCC影响测量能够更好地估计和解释比较有效性研究中患者病例组合和PRO结果的差异。
英文摘要
DESCRIPTION (provided by applicant): It is well documented that multimorbidity, or multiple chronic conditions (MCC), impairs patients' functioning and health-related quality of life (QOL). However, our ability to study the impact of and account for multimorbidity is hampered by methodological problems underlying its conceptualization and measurement. These include lack of a uniform definition, proliferation of diverse multimorbidity indexes, widespread reliance on indexes using population weights that were not developed to explain variations in patients' QOL, and a paucity of indexes that take individual assessments of disease burden into account. The goal of this project is to improve the assessment of MCC impact for the purposes of analyzing and interpreting generic patient- reported outcome (PRO) measures of QOL. We will conduct secondary analyses of cross-sectional and longitudinal data collected in 2011 and 2012 for 10,624 adults from two independent samples (one sampled to represent the US general population and a second cohort oversampled from adults pre-identified with arthritis, cardiovascular disease, chronic kidney disease, diabetes or respiratory disease), pursuant to the NIA- sponsored Computerized Adaptive Assessment of Disease Impact (DICAT) grant (R44 AG025589, Ware, PI). For 36 conditions, DICAT developed standardized disease-specific scales measuring the QOL impact attributed to each condition. These condition-specific QOL impact scores have been evaluated on a disease- by-disease basis but have not been evaluated collectively to determine how well they measure multimorbidity and its impact. We propose to extend this work to better understand the ability of patients to make valid QOL attributions to individual conditions in the context of MCC. We will also determine the importance of differences in alternative approaches to aggregating condition-specific patient QOL impact ratings in the presence of MCC, specifically for purposes of analyzing and interpreting generic PROs. The project has the following specific aims: (1) Explore the extent to which patients with MCC can make valid attributions to specific conditions when reporting disease impact on QOL. (2) Systematically evaluate different MCC aggregation methods used to predict generic PRO outcomes. (3) Cross-validate methods and results with independent data. Additional research will likely be required to fully implement the methodological advances proven to be useful in this research. However, the approach to conceptualizing and measuring MCC impact evaluated in this project ultimately may enable the use of standardized PRO-based MCC impact measures to better estimate and interpret differences in patient case-mix and PRO outcomes in comparative effectiveness research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vision-QOL-CAT: A Functional Health CAT for those with Visual Disorders
  • 批准号:
    8057033
  • 项目类别:
  • 资助金额:
    $9.86万
  • 财政年份:
    2011
  • 负责人:
    JOHN E WARE
  • 依托单位:
Development of a Functional Health CAT for Managing Obesity
  • 批准号:
    7272258
  • 项目类别:
  • 资助金额:
    $12.52万
  • 财政年份:
    2007
  • 负责人:
    JOHN E WARE
  • 依托单位:
Functional Health CAT in Chronic Kidney Disease
  • 批准号:
    7053957
  • 项目类别:
  • 资助金额:
    $68.6万
  • 财政年份:
    2006
  • 负责人:
    JOHN E WARE
  • 依托单位:
Functional Health CAT in Chronic Kidney Disease
  • 批准号:
    7227816
  • 项目类别:
  • 资助金额:
    $74.91万
  • 财政年份:
    2006
  • 负责人:
    JOHN E WARE
  • 依托单位:
海外基金